MG

Medtec Medizintechnik Gmbh

www.mbst.de link_icon

Company Market Research Report: MedTec Medizintechnik GmbH



Company Overview



  • Name: MedTec Medizintechnik GmbH

  • Mission: To enhance the quality of life through research by understanding the causes of degenerative diseases and treating them effectively and sustainably with the non-invasive MBST therapy.

  • Founded: 1998

  • Founder: Axel Muntermann

  • Key People: Axel Muntermann (Founder)

  • Headquarters: Sportparkstr. 9, 35578 Wetzlar, Germany

  • Number of Employees: No information is available

  • Revenue: No information is available

  • Known For: Pioneering the innovative MBST (Molecular Biophysical Stimulation Therapy) technology, a therapeutic system applied globally across human, veterinary, and cosmetic medicine.


Products



Therapeutic Devices


Under the brand MBST, MedTec offers several therapeutic devices designed to treat various degenerative conditions and injuries using core spin resonance technology. Here are some key products:

1. ARTHRO·SPIN·FLEX
  • Description: A therapy bed for treating the shoulder, spine, intervertebral discs, hip, leg, and double knee.

  • Features:

  • DUAL Core Spin Resonance System

  • Flexible ergonomic positioning system

  • Magnetic resonance quality monitoring

  • Circadian clock device for cell rhythm regulation


2. ARTHRO·SPIN·LIFT
  • Description: A portable and adjustable therapy device for treating arms, elbows, hands, fingers, legs, knees, feet, and toes.

  • Features:

  • SOFTMOVE Ergonomic Positioning

  • Vacuum Encapsulated Drive Coils

  • Designed for patient comfort, with easy movement and positioning


3. OSTEO·SPIN
  • Description: A full-body therapy system aimed at treating skeletal structures such as osteopenia and osteoporosis.

  • Features:

  • DUAL Core Spin Resonance System

  • Full-body treatment capabilities

  • Circadian clock device for improving metabolic rhythms


Recent Developments



Product Developments and Launches


  • OSTEO·SPIN devices have been launched, which cater extensively to bone-related conditions like osteoporosis, providing whole-body therapeutic options.

  • MBST therapy has been expanded to address chronic Athroses, disc diseases, and other muscle-bone disorders.


Certifications and Awards


  • MedTec achieved the MDR 2017/745 certification, making it among the first firms to comply with these stringent EU directives, underscoring the safety and efficacy of its products.

  • Awarded the German Innovation Award 2022 for the next generation of therapy devices and innovative communication concepts.


Industry Recognition


  • Recognized as a Top 100 Innovator in Germany multiple times, reflecting consistent innovation and future-oriented thinking.

  • Received the German Brand Award for "Health & Pharmaceuticals" reflecting its leading position as a therapeutic brand.


Strategic Partnerships


  • New MBST-treatment centers have been established in regions like the UK and India, expanding its global reach.

  • Partnerships with esteemed medical universities and research facilities continue to back the scientific credibility of MBST therapies.


Key Strategic Initiatives


  • Ongoing investment in scientific studies and clinical evaluations to bolster the credibility and reach of the MBST therapy.

  • Continuous development of new therapeutic devices to expand and diversify treatment capabilities across various medical conditions.


Conclusion



MedTec Medizintechnik GmbH stands at the forefront of innovation in the field of therapeutic medical technologies and has established itself as a global leader with its MBST therapy systems. The company's emphasis on chronic and degenerative disease management through non-invasive methods, coupled with its strong foundation in research and innovation, continues to drive its growth and influence in the healthcare sector.